Charles C. Muscoplat
University of Minnesota
Charles Muscoplat completed his PhD, in 1974 from University of Minnesota with a major in Immunology and Microbiology, and later completed postdoctoral studies in immunology at the Memorial Sloan-Kettering Cancer Center in New York, NY. Dr. Muscoplat received his B.A. degree in 1970 majoring in Chemistry and minoring in mathematics. Dr. Muscoplat was a faculty member at the University of Minnesota in Veterinary Medicine from 1976 until 1981. Dr. Muscoplat spent nearly 20 years, from early 1981 until 1999, as the Vice President for Medical Affairs and Business Development at MGI Pharma, Inc., where he lead the research and development teams for gaining FDA approval for two commercial drugs; Salagen™ for treatment of xerostomia in head and neck cancer patients and also for treatment of xerostomia and sicca syndrome in patients with Sjogren’s Syndrome. Also at MGI, Dr. Muscoplat was responsible for business development and funding of research leading to the successful commercial development of commercial biotechnology-derived corn products for agriculture and for monoclonal antibodies for veterinary medicine. From 1999 until 2006 he was Vice President and Dean of the College of Agricultural, Food and Environmental Sciences at the University of Minnesota and he currently holds a McKnight Presidential Leadership Professor chair. He is Professor of Food Science and Nutrition and also is an Adjunct Professor of Medicine in the Medical School. Dr. Muscoplat now conducts clinical research using transdermal vitamin d to bypass malabsorption disorders in Cystic Fibrosis patients. Dr. Muscoplat also currently teaches undergraduates.
Nutrigenomics Gene diet interactions Vitamin D